Paper Details

  1. Home
  2. Paper Details

Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.

Author: Al-SamkariHanny

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Chemotherapy-induced thrombocytopenia (CIT) is a common complication of cancer treatment. This review discusses the use of thrombopoietin receptor agonists (TPO-RAs) for managing CIT. TPO-RAs have shown promise in clinical trials and offer a safe and effective option for preventing and managing CIT.
Paper Details　
Original Abstract of the Article :
Chemotherapy-induced thrombocytopenia (CIT) is a common complication of antineoplastic therapy, resulting in antineoplastic therapy dose reductions, treatment delays, treatment discontinuation, and morbid bleeding events. Despite several decades of research into thrombopoietic growth factors in CIT,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.blre.2023.101139

データ提供：米国国立医学図書館（NLM）

Thrombopoietin Receptor Agonists: A New Frontier in Chemotherapy-Induced Thrombocytopenia Management

Chemotherapy-induced thrombocytopenia (CIT) is a common and potentially serious side effect of cancer treatment. This review examines the use of thrombopoietin receptor agonists (TPO-RAs) in the management and prevention of CIT. The authors discuss the evidence supporting the efficacy and safety of TPO-RAs, particularly romiplostim and avatrombopag, in patients with solid tumors. They provide detailed guidance for the use of TPO-RAs in clinical practice and highlight ongoing clinical trials evaluating their role in managing CIT.

TPO-RAs: A Powerful Tool for Managing CIT and Improving Patient Outcomes

This review highlights the significant potential of TPO-RAs to improve the management of CIT. These agents can help prevent dose reductions, treatment delays, and treatment discontinuation, ultimately leading to better outcomes for patients with cancer. It's like finding a hidden oasis in the desert of cancer treatment, providing a lifeline for patients facing the challenges of CIT.

A Personalized Approach to CIT Management: Navigating the Desert of Side Effects

This review emphasizes the importance of a personalized approach to managing CIT. TPO-RAs can be effective tools, but their appropriate use requires careful consideration of individual patient factors. This personalized approach, like a skilled camel navigating a challenging desert landscape, can help us minimize the adverse effects of CIT and maximize the benefits of cancer treatment.

Dr. Camel's Conclusion

This review provides a valuable overview of the use of TPO-RAs in managing CIT. These agents offer a promising approach to mitigating the side effects of chemotherapy and improving the quality of life for cancer patients. This research is a testament to the ongoing efforts to develop innovative therapies and improve the care of cancer patients. It's a reminder that even in the midst of challenging journeys, there are always new opportunities for healing and hope.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-01
Further Info :

Pubmed ID

37914568

DOI: Digital Object Identifier

10.1016/j.blre.2023.101139

Related Literature

Article Analysis
・Effects of avatrombopag
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.